Naviter Wealth’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,151
| Closed | -$8.24K | – | 287 |
|
|
2025
Q1 | $8.24K | Hold |
3,151
| – | – | ﹤0.01% | 273 |
|
|
2024
Q4 | $13.9K | Sell |
3,151
-2,102
| -40% | -$9.27K | ﹤0.01% | 278 |
|
|
2024
Q3 | $82.7K | Hold |
5,253
| – | – | 0.01% | 240 |
|
|
2024
Q2 | $144K | Hold |
5,253
| – | – | 0.02% | 225 |
|
|
2024
Q1 | $189K | Hold |
5,253
| – | – | 0.03% | 218 |
|
|
2023
Q4 | $141K | Sell |
5,253
-33
| -0.6% | -$889 | 0.03% | 210 |
|
|
2023
Q3 | $173K | Sell |
5,286
-74
| -1% | -$2.42K | 0.04% | 200 |
|
|
2023
Q2 | $182K | Buy |
5,360
+49
| +0.9% | +$1.66K | 0.05% | 219 |
|
|
2023
Q1 | $271K | Buy |
5,311
+3
| +0.1% | +$153 | 0.09% | 169 |
|
|
2022
Q4 | $387K | Buy |
+5,308
| New | +$387K | 0.11% | 166 |
|
|
2022
Q3 | – | Sell |
-5,243
| Closed | -$814K | – | 186 |
|
|
2022
Q2 | $814K | Buy |
5,243
+6
| +0.1% | +$932 | 0.33% | 71 |
|
|
2022
Q1 | $3.22M | Buy |
5,237
+52
| +1% | +$32K | 1.07% | 32 |
|
|
2021
Q4 | $6.49M | Buy |
+5,185
| New | +$6.49M | 1.94% | 11 |
|